CXCL1 and neoplasm: A decrease in PMN-MDSC recruitment has been observed after the use of Sema4D mAb to treat murine oral cancer 1 (MOC1); this phenomenon is associated with decreased expression of MAPK-dependent chemokines such as CXCL1, 2, and 5 in tumor cells86.